Carcinogenesis and cellular immortalization without persistent inactivation of p16/Rb pathway in lung cancer

International Journal of Oncology

Volumn 36, Issue 5, 2010, Pages 1217-1227

  Arifin, Marina ^a   Tanimoto, Keiji ^a   Putra, Andika Chandra ^a   Hiyama, Eiso ^a   Nishiyama, Masahiko ^a,b   Hiyama, Keiko ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b SAITAMA MEDICAL UNIVERSITY INTERNATIONAL MEDICAL CENTER   (Japan)

Author keywords

Adenocarcinoma; Cancer stem cells; Cellular immortalization; Lung cancer; p16 Rb pathway; Telomerase

Indexed keywords

CISPLATIN; PROTEIN P16; RETINOBLASTOMA PROTEIN; TELOMERASE;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER STEM CELL; CELL IMMORTALIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE INACTIVATION; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG CARCINOGENESIS; LUNG SQUAMOUS CELL CARCINOMA; MALE; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

ADENOCARCINOMA; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CISPLATIN; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; RETINOBLASTOMA PROTEIN; STEM CELLS; TELOMERASE;

EID: 77950454451     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000605     Document Type: Article

References (27)

1. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, Visvader J, Weissman IL and Wahl GM: Cancer stem cells - perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 66: 9339-9344, 2006.
2. Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, Di Virgilio A, Conticello C, Ruco L, Peschle C and De Maria R: Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 15: 504-514, 2008.
3. Mizrak D, Brittan M and Alison MR: CD133: molecule of the moment. J Pathol 214: 3-9, 2008.
4. Hirschmann-Jax C, Foster AE, Wulf GG, Nuchtern JG, Jax TW, Gobel U, Goodell MA and Brenner MK: A distinct 'side population' of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci USA 101: 14228-14233, 2004.
5. Jiang F, Qiu Q, Khanna A, Todd NW, Deepak J, Xing L, Wang H, Liu Z, Su Y, Stass SA and Katz RL: Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Mol Cancer Res 7: 330-338, 2009.
6. - subpopulations of A549 and H446 cells contain cancerinitiating cells. Cancer Sci 100: 1040-1046, 2009.
7. Lobo NA, Shimono Y, Qian D and Clarke MF: The biology of cancer stem cells. Annu Rev Cell Dev Biol 23: 675-699, 2007.
8. Hiyama E and Hiyama K: Telomere and telomerase in stem cells. Br J Cancer 96: 1020-1024, 2007.
9. Hiyama K, Hiyama E, Tanimoto K and Nishiyama M: Role of telomeres and telomerase in cancer. In: Telomeres and Telomerase in Cancer. Hiyama K (ed.). Humana Press, Springer, New York, NY, pp171-180, 2009.
10. INK4A participates in a G1 arrest checkpoint in response to DNA damage. Mol Cell Biol 18: 378-387, 1998.
11. Shay JW and Wright WE: Senescence and immortalization: role of telomeres and telomerase. Carcinogenesis 26: 867-874, 2005.
12. Arifin M, Hiyama K, Tanimoto K, Wiyono WH, Hiyama E and Nishiyama M: EGFR activating aberration occurs independently of other genetic aberrations or telomerase activation in adenocarcinoma of the lung. Oncol Rep 17: 1405-1411, 2007.
13. Sobin LH, Hermanek P and Hutter RV: TNM classification of malignant tumors. A comparison between the new (1987) and the old editions. Cancer 61: 2310-2314, 1988.
14. Hiyama K, Hiyama E, Ishioka S, Yamakido M, Inai K, Gazdar AF, Piatyszek MA and Shay JW: Telomerase activity in small-cell and non-small-cell lung cancers. J Natl Cancer Inst 87: 895-902, 1995.
15. Hiyama K, Ishioka S, Shirotani Y, Inai K, Hiyama E, Murakami I, Isobe T, Inamizu T and Yamakido M: Alterations in telomeric repeat length in lung cancer are associated with loss of hetero-zygosity in p53 and Rb. Oncogene 10: 937-944, 1995.
16. Mendoza C, Sato H, Hiyama K, Ishioka S, Isobe T, Maeda H, Hiyama E, Inai K and Yamakido M: Allelotype and loss of heterozygosity around the L-myc gene locus in primary lung cancers. Lung Cancer 28: 117-125, 2000.
17. Tanaka T, Tanimoto K, Otani K, Satoh K, Ohtaki M, Yoshida K, Toge T, Yahata H, Tanaka S, Chayama K, Okazaki Y, Hayashizaki Y, Hiyama K and Nishiyama M: Concise prediction models of anticancer efficacy of 8 drugs using expression data from 12 selected genes. Int J Cancer 111: 617-626, 2004.
18. Hiyama K, Tanimoto K, Nishimura Y, Tsugane M, Fukuba I, Sotomaru Y, Hiyama E and Nishiyama M: Exploration of the genes responsible for unlimited proliferation of immortalized lung fibroblasts. Exp Lung Res 34: 373-390, 2008.
19. Herman JG, Graff JR, Myohanen S, Nelkin BD and Baylin SB: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93: 9821-9826, 1996.
20. Hiyama K, Hiyama E and Shay JW: Telomeres and telomerase in humans. In: Telomeres and Telomerase in Cancer. Hiyama K (ed.). Humana Press, Springer, New York, NY, pp3-21, 2009.
21. Hiyama E, Hiyama K, Yokoyama T and Shay JW: Immunohistochemical detection of telomerase (hTERT) protein in human cancer tissues and a subset of cells in normal tissues. Neoplasia 3: 17-26, 2001.
22. Kumazaki T, Hiyama K, Takahashi T, Omatsu H, Tanimoto K, Noguchi T, Hiyama E, Mitsui Y and Nishiyama M: Differential gene expressions during immortalization of normal human fibroblasts and endothelial cells transfected with human telomerase reverse transcriptase gene. Int J Oncol 24: 1435-1442, 2004.
23. Miyazu YM, Miyazawa T, Hiyama K, Kurimoto N, Iwamoto Y, Matsuura H, Kanoh K, Kohno N, Nishiyama M and Hiyama E: Telomerase expression in non-cancerous bronchial epithelia is a possible marker of early development of lung cancer. Cancer Res 65: 9623-9627, 2005.
24. INK4a and tobacco carcinogen exposure in nonsmall cell lung cancer. Int J Cancer 118: 1364-1369, 2006.
25. Yokota J and Kohno T: Molecular footprints of human lung cancer progression. Cancer Sci 95: 197-204, 2004.
26. Heppner GH: Tumor heterogeneity. Cancer Res 44: 2259-2265, 1984.
27. Lou H and Dean M: Targeted therapy for cancer stem cells: the patched pathway and ABC transporters. Oncogene 26: 1357-1360, 2007.